BQE helps fight MRSA

I think so anyway Viv. I see maybe 20% downside and 100% upside on these. BQE is already tackling MRSA in France and America. Whichever company cracks it will be a goldmine. It is a pity it has taken so long as had BQE finalised its solution in an election year- given the state of hospitals become so important then- I think it easily would have been a doublebagger. The last results weren't bad IMO. Throw in the wound healing technology which could SIGNIFICANTLY improve healing time and who knows what this company would be valued at.I always love the word "SIGNIFICANTLY" in annual reports. It has held up so far after a 45% spike and jumped on low volume as you said so who knows what's round the corner.